A Germline ZFX Missense Variant in a Patient With Primary Hyperparathyroidism

Bin Guan1, Sunita K Agarwal2, James M Welch2

  • 1Ophthalmic Genomics Laboratory, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

JCEM Case Reports
|July 26, 2024
PubMed
Summary

A patient with primary hyperparathyroidism (PHPT) and developmental anomalies was found to have a de novo ZFX gene variant. This finding suggests ZFX gene testing may benefit PHPT patients with congenital anomalies.